Sandra Pietri

Title: Sandra Pietri: Innovator in Mesenchymal Stem Cell Research

Introduction

Sandra Pietri is a notable inventor based in Moha, Belgium. She has made significant contributions to the field of stem cell research, particularly in the differentiation of mesenchymal stem cells (MSC). Her innovative methods have the potential to enhance transplantation properties, making her work crucial in regenerative medicine.

Latest Patents

Sandra Pietri holds a patent for "Methods for differentiating mesenchymal stem cells." This patent discloses a method for obtaining MSC-derived cells with improved transplantation properties. The method includes a cell size reduction step, characterized by contacting MSC or MSC-derived cells in vitro or ex vivo with heparin or a derivative or analogue thereof at a concentration of at least 0.01 IU/ml. Additionally, the application provides a method for obtaining mesenchymal stem cell-derived cells from MSC by contacting them with FGF-2, TGF-β, and at least 0.01 IU/ml heparin or a derivative or analogue thereof. The invention also encompasses the so-obtained cells and cell populations, along with further products comprising such and their uses.

Career Highlights

Throughout her career, Sandra has worked with various companies, including Bone Therapeutics S.A. and Biosenic S.A. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in stem cell therapies.

Collaborations

Sandra Pietri has collaborated with notable professionals in her field, including Xuan Mai Nguyen and Enrico Bastianelli. These collaborations have further enriched her research and development efforts.

Conclusion

Sandra Pietri's work in mesenchymal stem cell differentiation showcases her innovative spirit and dedication to advancing medical science. Her contributions are paving the way for improved therapeutic options in regenerative medicine.